The Journal of Organic Chemistry
Article
Figure 7. Electrostatic potential for Ph-urea 5a and two anion complexes: (a) 5a, (b) 5a + F− and (c) 5a + SCN−. The electrostatic potential (in au)
is represented over a constant electronic isodensity ρ (in Å−3) surfaces of volume Vs (in Å−3). All three figures correspond to ρ = 0.05 Å−3, and the
potential varies: (a) from B = 0.33 (dark blue) to A = −0.17 (red) for the receptor; (b) from B = 0.13 (dark blue) to A = −0.31 (red) for the
complex 5a-F− and (c) from B = 0.07 (dark blue) to A = −0.37 (red) for the complex 5a-SCN−.
126.1, 128.0 (ArH), 123.3, 128.0, 132.8, 133.3, 142.2, 147.0, 151.0,
151.7 (ArH). Anal. Calcd for C53H68N2O5: C, 78.29; H, 8.43; N, 3.45.
Found: C, 78.54; H, 8.74; N, 3.61.
39.2 (ArCH2Ar), 31.4, 31.5, 31.6 (2C) [C(CH3)], 32.1, 32.2
(OCH2CH2CH2CH3), 34.1 (2C), 34.2, 34.3 [C(CH3)], 64.6, 68.5
(CH2OCH2), 70.3, 70.4, 73.9, 75.4 (OCH2CH2CH2CN and
OCH2CH2CH2CH3), 119.7, 121.1 (CN), 125.3, 125.9, 126.2, 126.7,
126.8, 126.9, 127.0, 128.2 (ArH), 130.2, 130.6, 132.9, 133.2, 133.4,
133.44, 134.5, 143.53, 145.3, 145.4, 145.8, 146.6, 152.4, 152.9, 153.7,
154.3 (Ar). Anal. Calcd for C61H84N2O5: C, 79.18; H, 9.15; N, 3.03.
Found: C, 78.79; H, 9.06; N, 3.21.
7,13,19,25-Tetra-tert-butyl-27,29-bis[(cyanopropyl)oxy]-28,30-di-
butoxy-2,3-dihomo-3-oxacalix[4]arene (3). A mixture of 2 (1.0 g,
1.23 mmol) and 0.30 g (7.4 mmol) of NaH (60% oil dispersion) in 40
mL of THF−DMF (7:1, v/v) was stirred under an atmosphere of N2.
After 1 h, 0.85 mL (7.4 mmol) of 1-iodobutane was added, and the
mixture was refluxed and stirred for 14 h. After cooling, the solvent
was evaporated, and the residue was dissolved in CH2Cl2 (75 mL) and
washed with 1 M HCl (2 × 40 mL), NH4Cl saturated solution (3× 30
mL), and brine (40 mL). The organic layer was dried over Na2SO4
and filtered, and the solvent was removed under reduced pressure. The
crude product was subjected to flash chromatography on silica gel
(eluent gradient from n-heptane/ethyl acetate 95:5 to 90:10) to give 3
as a white solid in the cone (0.55 g, 54% yield) and partial cone A
conformations (0.14 g, 14% yield).
7,13,19,25-Tetra-tert-butyl-27,29-bis[(aminobutyl)oxy]-28,30-di-
butoxy-2,3-dihomo-3-oxacalix[4]arene (4). To a suspension of 1.0 g
(1.08 mmol) of 3 (cone conformation) and 1.54 g (6.48 mmol) of
CoCl2·6H2O in MeOH (35 mL) was slowly added 0.85 g (21.6 mmol)
of NaBH4. A black suspension was formed that was stirred at room
temperature for 24 h. Then, another portion of NaBH4 (0.85 g) was
added, and the suspension was stirred for an additional 24 h. A 25%
ammonia solution (110 mL) was added, and the mixture was stirred
overnight. The solution was extracted with CH2Cl2 (3 × 50 mL) and
dried over Na2SO4, and the solvent evaporated to dryness to afford
diamine 4 as a beige solid (88% yield), which was pure enough to be
Cone: mp 104−106 °C; IR (KBr) 2247 cm−1 (CN); 1H NMR
(CDCl3, 500 MHz) δ 0.65, 1.04, 1.23, 1.34 [4s, 36H, C(CH3)], 1.01,
1.03 (2t, 6H, J = 7.4 Hz, CH3), 1.47, 1.55 (2m, 4H,
OCH2CH2CH2CH3), 1.84 (m, 4H, OCH2CH2CH2CH3), 2.16, 2.28,
2.37, (3m, 4H, OCH2CH2CH2CN), 2.60, 2.66 (2m, 4H,
OCH2CH2CH2CN), 3.22, 4.30 (ABq, 2H, J = 13.9 Hz, ArCH2Ar),
3.23, 4.34 (ABq, 2H, J = 12.9 Hz, ArCH2Ar), 3.26, 4.32 (ABq, 2H, J =
13.0 Hz, ArCH2Ar), 3.59, 3.74, 3.85, 4.02 (4m, 8H,
OCH2CH2CH2CH3 and OCH2CH2CH2CN), 4.33, 4.65 (ABq, 2H, J
= 13.2 Hz, CH2OCH2), 4.65, 4.77 (ABq, 2H, J = 13.0 Hz, CH2OCH2),
6.28, 6.79, 6.85, 6.89, 7.10, 7.12, 7.20, 7.22 (8d, 8H, ArH); 13C NMR
(CDCl3, 125.8 MHz) δ 14.0 (2C) [O(CH2)3CH3], 14.1, 14.4, 19.3,
19.5 (OCH2CH2CH2CN and OCH2CH2CH2CH3), 26.1, 26.3
(OCH2CH2CH2CN), 29.7, 30.1, 30.5 (ArCH2Ar), 31.2 (2C), 31.5,
31.6 [C(CH3)], 32.4, 32.5 (OCH2CH2CH2CH3), 33.8, 33.9, 34.2, 34.3
[C(CH3)], 67.7, 68.2 (CH2OCH2), 71.9 (2C), 74.8, 75.6
(OCH2CH2CH2CN and OCH2CH2CH2CH3), 119.7, 120.3 (CN),
123.2, 124.3, 124.6, 125.1, 125.4, 126.5, 126.6, 127.0 (ArH), 130.0,
131.9, 132.3, 132.4, 132.6, 133.7, 133.9, 135.2,144.8, 145.3, 145.8,
145.9, 151.3, 151.9, 152.0, 152.9 (Ar). Anal. Calcd for C61H84N2O5: C,
79.18; H, 9.15; N, 3.03. Found: C, 78.92; H, 9.12; N, 3.21.
1
immediately used in the next step: H NMR (CDCl3, 500 MHz) δ
0.90, 0.99, 1.16, 1.20 [4s, 36H, C(CH3)], 1.00, 1.01 (2t, 6H, J = 7.4
Hz, CH3), 1.42−1.67, 1.77−2.05 (several m, 16H, OCH2CH2CH2CH3
a n d O C H 2 C H 2 C H 2 C H 2 N H 2 ) , 2 . 7 9 ( 2 t , 4 H ,
OCH2CH2CH2CH2NH2), 3.18, 4.38 (ABq, 2H, J = 13.2 Hz,
ArCH2Ar), 3.18, 4.40 (ABq, 2H, J = 13.2 Hz, ArCH2Ar), 3.22, 4.39
(ABq, 2H, J = 13.0 Hz, ArCH2Ar), 3.61−3.90 (several m, 8H,
OCH2CH2CH2CH3 and OCH2CH2CH2CH2NH2), 4.59, 4.64 (ABq,
2H, J = 13.1 Hz, CH2OCH2), 4.59, 4.68 (ABq, 2H, J = 13.1 Hz,
CH2OCH2), 6.62, 6.81, 6.93, 6.94, 6.97, 7.00, 7.03, 7.07 (8d, 8H,
ArH).
Procedure for the Synthesis of Ureas 5a, 5b, and 5c. To a
solution of 4 (0.90 g, 0.966 mmol) in CHCl3 (30 mL) was added 1.93
mmol of the appropriate isocyanate. The mixture was stirred at room
temperature under N2 for 4 h. Evaporation of the solvent yielded the
crude products which were purified as described below.
7,13,19,25-Tetra-tert-butyl-27,29-bis[[(N′-phenylureido)butyl]-
oxy]-28,30-dibutoxy-2,3-dihomo-3-oxacalix[4]arene (5a). Flash
chromatography (SiO2, eluent CH2Cl2/MeOH, from 99:1 to 97:3)
was followed by recrystallization from MeOH: 45% yield (0.56 g); mp
214−216 °C; IR (KBr) 3327 cm−1 (NH), 1647 cm−1 (CO); 1H NMR
(CDCl3, 500 MHz) δ 0.55, 1.08, 1.33, 1.37 [4s, 36H, C(CH3)], 0.91,
0.94 (2t, 6H, J = 7.4 Hz, CH3), 1.44 (m, 4H, OCH2CH2CH2CH3),
1.50, 1.78, 1.92, 2.27 (4m, 12H, OCH2CH2CH2CH2NHa and
OCH2CH2CH2CH3), 3.20, 4.31 (ABq, 2H, J = 14.1 Hz, ArCH2Ar),
3.21, 4.30 (ABq, 2H, J = 12.7 Hz, ArCH2Ar), 3.22, 4.38 (ABq, 2H, J =
1 2. 6 H z , A r C H2 Ar), 3. 2 1, 3. 35, 3 . 55 (3m, 4H,
OCH2CH2CH2CH2NHa), 3.47, 3.58−3.81, 3.90, 3.99 (several m,
8H, OCH2CH2CH2CH3 and OCH2CH2CH2CH3), 4.39, 4.91 (ABq,
2H, J = 13.2 Hz, CH2OCH2), 4.40, 5.15 (ABq, 2H, J = 12.6 Hz,
CH2OCH2), 5.82, 6.27 (2t, 2H, NHa), 6.13, 6.47, 6.76, 6.94, 7.12, 7.20,
7.30, 7.31 (8d, 8H, ArH), 6.96, 7.01 (2t, 2H, Ph-Hp), 7.25, 7.27 (2t,
1
Partial cone A: mp 108−110 °C; IR (KBr) 2243 cm−1 (CN); H
NMR (CDCl3, 500 MHz) δ 0.73 (m, 4H, OCH2CH2CH2CN
inverted), 0.96, 0.97 (2t, 6H, J = 7.4 Hz, CH3), 1.21, 1.25, 1.38,
1.39 [4s, 36H, C(CH3)], 1.38 (m, 4H, OCH2CH2CH2CH3), 1.66,
1.75, 1.92, 2.37 (4m, 10H, OCH2CH2CH2CH3, OCH2CH2CH2CN
and OCH2CH2CH2CN inverted), 3.30, 4.39 (ABq, 2H, J = 13.1 Hz,
ArCH2Ar), 3.31, 4.28 (ABq, 2H, J = 13.1 Hz, ArCH2Ar), 3.49−3.77
(several m, 6H, OCH2CH2CH2CH3 and OCH2CH2CH2CN), 3.81,
3.88 (ABq, 2H, J = 15.8 Hz, ArCH2Ar), 4.10, 5.05 (ABq, 2H, J = 11.9
Hz, CH2OCH2), 4.11 (s, 2H, CH2OCH2), 7.03, 7.05, 7.16, 7.22, 7.24,
7.32, 7.33 (7d, 8H, ArH); 13C NMR (CDCl3, 125.8 MHz) δ 12.2, 13.2
(OCH2CH2CH2CN inverted and OCH2CH2CH2CN), 14.0 (2C)
[O(CH2)3CH3], 19.2, 19.3 (OCH2CH2CH2CH3), 25.2, 26.1
(OCH2CH2CH2CN inverted and OCH2CH2CH2CN), 29.1, 30.1,
4H, Ph-Hm), 7.46, 7.4 (2d, 4H, Ph-Ho), 7.96, 8.05 (2s, 2H, NHb); 13
C
H
dx.doi.org/10.1021/jo4026012 | J. Org. Chem. XXXX, XXX, XXX−XXX